chrisvoncsefalvay/vaers-outcomes huggingface dataset:
INTENSE INSOMNIA; KIDNEY PAIN; SEVERE INCONTINENCE; BODY ACHES; SLEEP ISSUES; FEELING LIKE ACID HAS BEEN POURED ALL OVER BODY; SPINE WAS HOT TO THE TOUCH; OTHER AUTONOMIC PROBLEMS; BRAIN FOG; BARELY ABLE TO FUNCTION; SHIFT TO PAIN IN UPPER EXTREMITIES, CHEST, BACK, SHOULDERS, HEAD, NECK, AND OCCASIONALLY IN THE LOWER EXTREMITIES; VERY SWOLLEN AND TENDER LYMPH NODES; SEVERE HEADACHES; ABSOLUTELY EXHAUSTED; ACUTE PRESENTATION OF INTENSE TINGLING IN  HANDS, ARMS, FEET, LEGS, AND LIPS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 21-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-OCT-2021, the patient experienced acute presentation of intense tingling in hands, arms, feet, legs, and lips. On an unspecified date, the patient experienced intense insomnia, kidney pain, severe incontinence, body aches, sleep issues, feeling like acid has been poured all over body, spine was hot to the touch, other autonomic problems, brain fog, barely able to function, shift to pain in upper extremities, chest, back, shoulders, head, neck, and occasionally in the lower extremities, very swollen and tender lymph nodes, severe headaches, and absolutely exhausted. Laboratory data (dates unspecified) included: Laboratory test (NR: not provided) found nothing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe incontinence, body aches, and spine was hot to the touch, had not recovered from severe headaches, sleep issues, intense insomnia, other autonomic problems, and the outcome of very swollen and tender lymph nodes, kidney pain, acute presentation of intense tingling in hands, arms, feet, legs, and lips, shift to pain in upper extremities, chest, back, shoulders, head, neck, and occasionally in the lower extremities, feeling like acid has been poured all over body, absolutely exhausted, barely able to function and brain fog was not reported. This report was non-serious.
Right LE cellulitis and bullae - Operations and invasive procedures: Bedside procedure:    - drained her abscess/blister areas were drained x 3 on the right lower extremity of her leg and foot. There was copious clear yellow drainage. I dressed with kerlix and light ace wrap            - - excisionally debrided the ulceration (skin / subcutaneous necrotic tissue) to the right foot today x 1 using a 15-blade, this was debrided down to healthy tissues. Patient tolerated well without any issues ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Pt recvd 2 doses of Engerix-B on 30APR91 & 30MAY91 respectively for the prevention of Hep-B; 18JUL91; Hep B core antibody positive;
Clt first noticed a blister at site of injection 8 am on 1-27-09.  On 1-28-09 area became red, swollen & sore; Clt developed HA & head felt warm.  No temp taken.  Today, 1-29-09, area is red, warm with increased swelling.  HA has persisted X 2 days & head still feels warm.  Advised clt to take pain reliever such as Ibuprofen & cold/hot compresses to site of discomfort.  Will call clt next week to assess status. 2-2-09 Left msg to return call. 2/4/09 Left msg to return call.  2/11/09 To client. Clt report sx lasted 1 week then resolved.  No further F/U.
Always dizzy when standing/moving around. Feel faint if moving around too fast or up for too long. It has been 13 days since 2nd vaccine. Blood pressure is low so trying to increase salt intake and drink lots of fluids. Have blood pressure cuff to log 2x per day. Have a appt with my cardiologist on 4/12. No changes yet.
Abdominal skin/under skin pain, started on July 28th, about 10 days after the Shingle vaccine. Singles-like rashes appeared last night on the front side of abdominal area. Five rashes within 1-2cm size were observed and pictures were taken. Pain last and spread to abdominal back side today (7/30). Purchased Advil for night usage.
I just had those two shots you take and I am not exhausted and not feeling real well or chipper today; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 72 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose1), for COVID-19 Immunisation. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "I just had those two shots you take and I am not exhausted and not feeling real well or chipper today".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Felt fine when sitting ( in monitoring room) but felt dizzy when she got up and started walking
The day following the vaccine injection, Sunday, January 24, as I was finishing a 45 minute hike I began feeling dizzy.  I made it home, then felt nauseous and threw up, more drive heaves than food.   I laid down for awhile.  Since then I have felt woozy when I get up and start moving around.  The wooziness comes and goes.   I still have the symptoms.
Information has been received from a physician concerning a 16 year old white female with no medical history and no allergies who on 21JUL1997 was vaccinated with a first dose of varicella virus vaccine live. There was no illness at the time of vaccination. On 17NOV2003 the patient developed chicken pox and a clinical diagnosis of varicella was made. It was reported that she had varicella like lesions that appeared all over her body.Unspecified medical attention was sought. No diagnostic lab tests were performed. No product quality complaint was involved. It was also reported that another patient was vaccinated with a dose of varicella vaccine live and developed chicken pox. Additional information has been requested.
Left arm had typical pain day of 13Oct & after shot 14Oct.; Arm felt fine until 17Oct2022 when an ache in left arm from shoulder to elbow started and continues; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Oct2022 at 13:00 as dose 4 (booster), single (Lot number: GJ2524) at the age of 60 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "known allergies : penicillin" (unspecified if ongoing), notes: known allergies : penicillin; "known allergies : trees" (unspecified if ongoing), notes: known allergies : trees; "known allergies : grass" (unspecified if ongoing), notes: known allergies : grass; "known allergies : molds" (unspecified if ongoing), notes: known allergies : molds; "known allergies : Weeds" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: if covid prior vaccination Yes. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer Unknown), for Covid-19 immunization; Covid-19 vaccine (Dose 2 , Manufacturer Unknown), for Covid-19 immunization; Covid-19 vaccine (Dose 3, Manufacturer Unknown), for Covid-19 immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 13Oct2022, outcome "not recovered", described as "Arm felt fine until 17Oct2022 when an ache in left arm from shoulder to elbow started and continues"; PAIN IN EXTREMITY (non-serious) with onset 13Oct2022, outcome "not recovered", described as "Left arm had typical pain day of 13Oct & after shot 14Oct.". It was unknown if therapeutic measures were taken as a result of pain in extremity, arthralgia.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, patient has not tested for COVID-19
mom stated about 6PM pt started crying unconsrollable, nothing would stop cry; mom unsure of how long pt cried but it was quite a while;
States had TDAP on 4/29/10. Had sore arm all week unable to sleep went to Urgent Care 5/7 & was given RX for ALEVE & a sling. No redness or swelling. Sore muscle type pain. 5/10 called states slightly better.
Fever of up to 102.9, chills, extreme headache, upper shoulder/lower neck pain. fatigue the next day
inject site large area, very red, hot to touch & itchy; pt's 4th dose;
Almost passed out, blurred vision, achy, weak, lost control of my urine  for about 15 minutes.   Drank water and orange juice.  Felt better.
Acute myopericarditis Chest pain developed 24 hours after vaccine administration. Presented to emergency department 48 hours after vaccine administration. Symptoms resolved after an additional 24 hours (72 hrs after vaccine) with administration of ibuprofen three times daily.
Patient experienced chest tightness unrelated to breathing 5 minutes following the administration of the vaccines.  Chest tightness lasted for 15 minutes until it dissipated.  Pneumovax was given first.
Was given Influenza on 8/31/009, stated left arm from shoulder to elbow painful for a few days. States had small reddened area at site of injection none noted today.
4-5 days p/vax intermittent fever, fine rash all over especially apparent on chest, elbows, knees;next day hands, faced eyes became swollen-saw PMD who prescribed DPH & eye drops;then entire body became swollen;to clinic next day & sent ER
the PEDVAX had 2 unspecified temperature excursions prior to administration; no adverse symptoms reported; the patient vaccinated with expired PEDVAX; Information has been received from a nurse referring to a patient with unknown age and gender. The patient's concomitant, medical history, drug reactions or allergies were not reported.  On 22-APR-2019, the patient was vaccinated with expired haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) (reported as "PEDVAX") (lot number: M032150; expiration date: 21-APR-2019; strength, dose and route were not reported), for prophylaxis. The nurse reported the haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) had 2 unspecified temperature excursions prior to administration (Improper storage of product in use). No adverse symptoms reported. The outcome of the events was unknown.
PATIENT REPORTS CONTINUED OUTBREAKS OF SHINGLES SINCE SECOND DOSE. PATIENT HAS NOT SEEN A DIMINISHED SEVERITY SINCE THE DOSE SERIES WAS COMPLETED. OUTBREAKS ARE STILL SEVERE AND THE SHINGRIX DOSE SERIES HAS NOT PROVIDED ANY RELIEF.
Within 3 minutes after vaccine patient expressed she was going to "pass out"  medics guided her to the floor. Medics and local EMS were present.  Patient was unresponsive and apneic w/ ashen color skin, EMS began stimulation efforts.  Patient began to arouse and breathe within 3 minutes of efforts.  Patient was transported to hospital.
Pain in should that has persisted over the following week after vaccination. Slight Tingling, pins and needle feeling, and numbness in left arm that has continued over the week following the vaccination.  All symptoms remain as of the one week mark (August 11th)
Vertigo; Fever; headaches; 16-years-old patient was administered Moderna's Covid-19 vaccine; Lethargy; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-years-old patient was administered Moderna's Covid-19 vaccine), LETHARGY (Lethargy), VERTIGO (Vertigo), PYREXIA (Fever) and HEADACHE (headaches) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-years-old patient was administered Moderna's Covid-19 vaccine), LETHARGY (Lethargy), PYREXIA (Fever) and HEADACHE (headaches). On 06-Apr-2021, the patient experienced VERTIGO (Vertigo). On 05-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16-years-old patient was administered Moderna's Covid-19 vaccine) had resolved. On 06-Apr-2021, VERTIGO (Vertigo) outcome was unknown. At the time of the report, LETHARGY (Lethargy), PYREXIA (Fever) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Caller does not know that their son shouldn't receive the vaccine.  This report refers to a case of Product administered to patient of inappropriate age, for mRNA-1273, lot # unknown. Based on the current available information and temporal association between the use of the product and the start date of the events, headache, pyrexia, vertigo, lethargy, a causal relationship cannot be excluded.   This case was linked to MOD21-071243, MOD21-071244 (E2B Linked Report).; Sender's Comments: This report refers to a case of Product administered to patient of inappropriate age, for mRNA-1273, lot # unknown. Based on the current available information and temporal association between the use of the product and the start date of the events, headache, pyrexia, vertigo, lethargy, a causal relationship cannot be excluded. MOD21-071243:same reporter MOD21-071244:same reporter
REKT ME; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose was not reported, once a total administered, start therapy date not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced rekt me. Laboratory data (dates unspecified) included: COVID-19 virus test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of rekt me was not reported. This report was non-serious.
Five minutes after FLUVIRIN injection, pt felt dizziness, skin itchy and slight difficulty breathing. Pt used personal Proair HFA inhaler and felt better within 5 minutes. Pt stated completely resolved of symptoms in 2 hours.
patient had fatigue or 1 week horrible chills for 1 week an dby 3rd day would wake up soaking wet. had a fever of 103. She said she felt like she had covid. had a throbbing headache throughout the week.
Left thigh swollen next day after vaccine given; size of Twinkie, today went down
injection site painful; swollen leg; tender to touch; heat was radiating on the site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen leg), TENDERNESS (tender to touch), VACCINATION SITE WARMTH (heat was radiating on the site) and VACCINATION SITE PAIN (injection site painful) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Sep-2021, the patient experienced PERIPHERAL SWELLING (swollen leg), TENDERNESS (tender to touch) and VACCINATION SITE WARMTH (heat was radiating on the site). On an unknown date, the patient experienced VACCINATION SITE PAIN (injection site painful). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 2 DF. At the time of the report, PERIPHERAL SWELLING (swollen leg), TENDERNESS (tender to touch), VACCINATION SITE WARMTH (heat was radiating on the site) and VACCINATION SITE PAIN (injection site painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  This is alarming since patient is skinny.
approx 8hr post vax pt devel lt facial numbness extending to lt ear;18hr post vax pt reported numbness extended to lt neck & shoulder;
Prior to 7/6/01 mostly joint pain mostly treatable w/ Motrin. after 7/6/01, head, neck, back, hands pain, joint pain. None of which occurred during study period, was out of work being treated by several doctors for 6 weeks. would have been longer, voluntarily went back to work to prevent FMLA, on doses of Vicodin for pain, still currently experience pain.
severe pain in neck and shoulder area, slight fever, swollen glands, affected vision for over five days
22JAN97 630AM 1st of 3 episodes of diarrhea;22JAN97 3AM exp sweating, dry mouth, sl hot & clammy;21JAN97 took DPH became stuffy;took sudafed 1PM 22JAN97 stuffiness & sinus h/a being relieved by sudafed;sneezy & eyes swollen;
Information has been received from a Registered Nurse (R.N.) concerning an 18 year old female patient with no known drug allergies/drug reactions who on 16-JAN-1996 was vaccinated with the first dose of VARIVAX (Merck) into her left thigh.  The patient received her second dose of VARIVAX (Merck) on 05-DEC-2007 into her right arm.  Concomitant therapy included hormonal contraceptives (unspecified).  It was reported that titer drawn in August showed that the patient failed to seroconvert.  The patient sought unspecified medical attention.  The outcome of the patient was unknown at the time of the report.  No further information is available.
09:50 AM Patient is feeling itchy in her chest area and slushed. Observed for rash in upper arm and chest. B/P 123/86 and HR 76. Stated she has no allergies and no breakfast this AM. Pretzel and water given. Patient states feeling better after 25 minutes. Patient exited
Mother called RN over. Daughter is not feeling well. Pallor noted and patient reported some nausea. Taken back to observation room to lie down. Patient had eaten muffin at breakfast. Patient reports feeling better after snack. Observed for 20 minutes. Mother is comfortable with leaving. Patient walked with mother. No issues.
This initial spontaneous report was received from a physician referring to a 7 week-old male infant. There was no pertinent medical history, concomitant medication, concurrent conditions or drug allergies/drug reactions described. On 03-SEP-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ oral solution (lot # K023157 with expiration date 23-JUL-2016, second dose; dose was not reported), that was exposed to out of normal storage temperature range. No adverse event was reported. Lab diagnostics test were not performed. It was unknown if the patient sought medical attention. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information is not expected as all correspondence was received.
Post vax, the pt developed a fever that persisted despite treatments with Tylenol and cold baths. The next day, he started convulsing, his eyes were dilated for quite a while, and he was lethargic for sometime. The rescue service was summoned and the child was taken to the ER. Upon arrival to the hospital, the fever had subsided and thereafter the pt recovered from the seizure. The reporter stated that the hospital associated the fever to vax. Also, the reporter expressed concern that since being vaccinated, the pt developed seizures every time he gets fever. He gets fevers 3 to 4 times a year.
Redness, slightly warm patch noticed on L upper deltoid when student came in for additional immunizations. Per student-had received TDAP and Hep B prior week, stated S/S had been here for a few days.
pt returned approx 1hr p/vax has fine rash over legs, arms, face & back;pt has hx of asthma but not taking regular meds for it;breathing tx as needed;recommended take to ER for tx;no NP or MD in clinic;
Headache & Myalgia missed some time from work due to the above symptoms following second dose
chest congestion, tightening in throat more noticeable when swallowing, swollen upper lip @ about 1:30PM, eye red & gunky, conjunctivitis;tight throat & swollen lip;
Patient received vaccine on 5/22/21 and noticed a large red rash on the arm that received vaccine on 5/27/21. Site is red, slightly inflamed but patient reports non-painful and non-itchy. She reports no other adverse events.
Patient received flu shot at the workplace clinic from Pharmacy. He noticed pain at the time of the shot and the next day began having considerable pain within his shoulder with limited movement. He waited several weeks hoping pain would subside but it did not. He saw his PCP and MD deduced that perhaps the immunization had been injected into the bursa or tendon and was causing inflammation and pain. The patient was given a cortisone injection (on 10/09/2017) to reduce inflammation and speed up healing. A second cortisone shot was needed a couple weeks later on 10/25/2017 for the pain and inflammation.
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were unknown. On 17-AUG-2016, the patient was vaccinated with M-M-R II (lot number and expiry date were not reported) (dosing regimen and frequency unknown), which was inadvertently administered with sodium chloride rather than the sterile diluent that was supplied (product preparation error). No concomitant medications were reported. There were no adverse effects reported. There was no product quality complaint (PQC) involved. Additional information is not expected as the reporter did not want to provide his demographics nor participate in the report.
Apnea and cyanosis: Child given vaccines in AM, was well most of the day, but that evening began crying inconsolably, then suddenly went limp and pale, became apneic with central cyanosis for about 20 seconds.  He recovered spontaneously and seemed his normal self in about 5 minutes.  He seemed sleepier than normal for the next 2 days but was otherwise well. He was hospitalized for 2 days, had a complete sepsis workup (blood, csf and urine cx, CXR) which were normal.  He also had a normal UGI.  He received 48 hours of IV antibiotics. He was sent home on an apnea monitor and has been well since.  Nurse follow up on 09/28/04 states: "Final diagnosis was ALTE (Acute Life Threatening Event) s/p immunizations. Additional symptoms include sweating and fever of 100.2."
pt recv vax 9OCT97 & 2 days later devel rash sever itching;saw MD who states it was allergic rxn to HBV given DPH;instructed pt not recv any more HBV;took 2 wk for sx to subside;rash which appeared was on both arms, legs, back & some on abd
tingling tongue immediately after but checked by medics and nothing serious. told to take an antihistamine. later that eve itchy eves and the next day a bad mood and my tongue peeled a little, briefly.  all pretty mild though.
Covid vaccination history: Pfizer Monovalent on 3.17.21, 4.12.21, and 10.19.21. On 8.8.23 at 8am Resident receive Pfizer Covid Bivalent vaccine. On 8.8.23 at 8:15am, Resident began to have slurred speech, hand and facial twitching, weakness, and was unable to follow directions.  She was sent to a loval health care facility. Per hospital notes, Residents fasting blood sugar was 40. She was treated with glucagon and symptoms subsided and Resident was alert and oriented x 3. This Resident has no history of Diabetes. Hospital notes state concern for possible ingestion of sulfonylurea vs injection of insulin. Toxicology labs for sulfonylurea pending. Insulin was NOT administered in place of COVID vaccine.